Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma Research Letter
| Authors: | Shitara, K.; Shah, M. A.; Lordick, F.; Van Cutsem, E.; Ilson, D. H.; Klempner, S. J.; Kang, Y. K.; Lonardi, S.; Hung, Y. P.; Yamaguchi, K.; Enzinger, P.; Nakajima, T.; Matsangou, M.; Cao, Y.; Li, R.; Moran, D.; Pophale, R.; Oh, M.; Ranganath, R.; Ajani, J. A.; Xu, R. H. |
| Title: | Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma |
| Keywords: | overall survival; fluorouracil; drug efficacy; antineoplastic agents; chemotherapy; antineoplastic agent; letter; adenocarcinoma; progression free survival; nausea; vomiting; pathology; monoclonal antibody; antibodies, monoclonal; health status; folinic acid; drug therapy; oxaliplatin; esophageal adenocarcinoma; stomach neoplasms; esophagus tumor; esophageal neoplasms; stomach tumor; esophagogastric junction; phase 3 clinical trial (topic); gastroesophageal junction adenocarcinoma; patient-reported outcome; gastroesophageal junction; gastroenterology; hematology/oncology; humans; human; gastrointestinal tract cancer; treatments in oncology; zolbetuximab |
| Journal Title: | New England Journal of Medicine |
| Volume: | 391 |
| Issue: | 12 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2024-09-26 |
| Start Page: | 1159 |
| End Page: | 1162 |
| Language: | English |
| DOI: | 10.1056/NEJMc2409512 |
| PUBMED: | 39282934 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
